4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. financial statements
4D Molecular Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 85.21M | 10-K |
| Net income | −USD 140.11M | 10-K |
| Cash and equivalents | USD 60.24M | 10-Q |
| Total debt | USD 0 | 10-Q |
4D Molecular Therapeutics, Inc. financials on 6ix · 4D Molecular Therapeutics, Inc. on 6ix